Bovie Medical, a maker of medical devices and supplies and the developer of J-Plasma, a patented new surgical product, announced that it has received FDA 510(k) approval for six new hand piece configurations that expand its J-Plasma pistol grip portfolio.
The pistol grip hand piece will now be available with instrument lengths of 15cm, 33cm and 45cm, in addition to the existing length of 27cm. Also, these new length hand pieces will each be available with a new needle configuration, as well as the standard blade configuration.
The new configurations have received FDA 510(k) approval and will be available beginning September 2015.
"In commercializing J-Plasma, we have implemented a voice of customer initiative that resulted in new designs to respond to specific surgical needs," said Robert L. Gershon, Chief Executive Officer.
"The new lengths of our pistol grip hand pieces offer surgeons greater access and increases the opportunity for adoption across multiple specialties, while the new needle tip configuration provides even more precision resulting in less collateral damage to unintended tissue."
Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma, a patented new plasma-based surgical product for cutting and coagulation.
J-Plasma utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery.